← All stocks

Paysign, Inc.

PAYS Net selling
CIK 0001496443 #2762 in the set updated 21 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$7.50M
$4.72M on a plan · $0.00 straight out of an exercise
Sold at will
$2.77M
9 of 19 sales
Net
−$7.50M
−$2.77M against sales at will

By person

15 insiders · 19 transactions
102×

Mark R. Newcomer holds 102 times base salary in stock. $107.61M of shares against $1.05M in salary for 2025.

Salary from the company's own proxy. The shares are what Mark R. Newcomer last reported holding, valued at $11.74, the price Common Stock was last bought or sold at on the open market here, on 16 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Herman Joan M
EVP, Operations
$2.47M (8) scheduled
−$2.47M
609,421
1.08%
$7.16M
−25.9%
Newcomer Mark
CEO
$2.25M (2) scheduled
−$2.25M
9,163,002
16.23%
$107.61M
−6.5%
Ngo Michael C
Chief Innovation Officer
$1.92M (2)
−$1.92M
2,811,336
4.98%
$33.02M
Baker Jeffery Bradford
Chief Financial Officer
$441.64K (1)
−$441.64K
542,171
0.9602%
$6.37M
+189.8%
Mina Bruce A
Director
$141.95K (2)
−$141.95K
278,500
0.4933%
$3.27M
+16.8%
Strobo Robert
Chief Legal Officer
$109.40K (1)
−$109.40K
526,871
0.9331%
$6.19M
+53.5%
Cunningham Bradley Kramer
Chief Technology Officer
$96.42K (2)
−$96.42K
314,622
0.5572%
$3.69M
−15.9%
Turner Matthew Baker
PRES., PATIENT AFFORDABILITY
$62.64K (1)
−$62.64K
404,262
0.7160%
$4.75M
+70.8%
Topline Capital Management, LLC entity
See Explanation in Footnotes
5,336,146
9.45%
$62.67M
−12.4%
Topline Capital Partners, LP entity
10% owner
5,336,146
9.45%
$62.67M
−12.4%
Spence Daniel
10% owner
4,295,000
7.61%
$50.44M
−53.3%
Triplett Dennis L
Director
290,000
0.5136%
$3.41M
+26.1%
Lanford Matthew Louis
Chief Payments Officer
273,424
0.4843%
$3.21M
+52.3%
HENRY DANIEL R
Director
169,884
0.3009%
$2.00M
+112.4%
NEWMAN JEFFREY B
Director
90,000
0.1594%
$1.06M
+200.0%
Insider
Date
Role
Action
Shares
Price
Amount
Herman Joan M
16 Sep 2026
EVP, Operations
Sold on a plan
38,900
$11.74
$456.83K
Herman Joan M
15 Sep 2026
EVP, Operations
Sold on a plan
21,004
$12.38
$260.07K
Ngo Michael C
9 Sep 2026
Chief Innovation Officer
Sell indirect
79,925
$12.74
$1.02M
Ngo Michael C
8 Sep 2026
Chief Innovation Officer
Sell indirect
70,075
$12.85
$900.42K
Baker Jeffery Bradford
12 Aug 2026
Chief Financial Officer
Sell
35,000
$12.62
$441.64K
Newcomer Mark
6 Aug 2026
CEO
Sold on a plan
150,000
$11.88
$1.78M
Newcomer Mark
29 Jul 2026
CEO
Sold on a plan
50,000
$9.38
$468.99K
Herman Joan M
16 Jul 2026
EVP, Operations
Sold on a plan
28,000
$8.69
$243.41K
Herman Joan M
15 Jul 2026
EVP, Operations
Sold on a plan
31,904
$8.60
$274.25K
Herman Joan M
26 Jun 2026
EVP, Operations
Sold on a plan
100,000
$8.01
$801.14K
Mina Bruce A
11 Jun 2026
Director
Sell
10,000
$7.10
$70.95K
Cunningham Bradley Kramer
1 Jun 2026
Chief Technology Officer
Sell
3,000
$7.80
$23.40K
Herman Joan M
1 Jun 2026
EVP, Operations
Sold on a plan
29,202
$8.00
$233.73K
Mina Bruce A
1 Jun 2026
Director
Sell
10,000
$7.10
$71.00K
Cunningham Bradley Kramer
29 May 2026
Chief Technology Officer
Sell
10,000
$7.30
$73.02K
Herman Joan M
26 May 2026
EVP, Operations
Sold on a plan
22,534
$7.01
$158.04K
Herman Joan M
4 May 2026
EVP, Operations
Sold on a plan
6,667
$7.01
$46.74K
Turner Matthew Baker
3 Feb 2026
PRES., PATIENT AFFORDABILITY
Sell
15,057
$4.16
$62.64K
Strobo Robert
12 Dec 2025
Chief Legal Officer
Sell
20,000
$5.47
$109.40K

What was left out

Form 4 filings counted 38
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 10
Sales straight out of an exercise 0
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 1,759,528
History held since 15 Nov 2016